Fifth Third Bancorp Pro Qr Therapeutics N.V. Transaction History
Fifth Third Bancorp
- $25.9 Billion
- Q1 2025
Shares
2 transactions
Others Institutions Holding PRQR
# of Institutions
78Shares Held
45MCall Options Held
31.4KPut Options Held
24.7K-
Adage Capital Partners Gp, L.L.C. Boston, MA9.6MShares$16.1 Million0.05% of portfolio
-
Privium Fund Management B.V.4.99MShares$8.38 Million3.12% of portfolio
-
Woodline Partners LP San Francisco, CA3.56MShares$5.98 Million0.07% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.83MShares$4.75 Million0.0% of portfolio
-
Affinity Asset Advisors, LLC New York, NY2.83MShares$4.75 Million1.38% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $120M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...